Avacta Group Plc (LON:AVCT) shares reached a new 52-week low on Monday . The stock traded as low as GBX 37 ($0.51) and last traded at GBX 37.50 ($0.52), with a volume of 14496 shares changing hands. The stock had previously closed at GBX 37.50 ($0.52).
Separately, FinnCap reiterated a “corporate” rating and issued a GBX 200 ($2.76) price target on shares of Avacta Group in a report on Monday, January 15th.
The stock has a market cap of $28.15 and a price-to-earnings ratio of -416.67.
Avacta Group Company Profile
Avacta Group plc is a biotechnology company. Avacta’s focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies.
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.